About

Provided by Jones Day

Our team in Japan prides itself on its longstanding local relationships, forged from the many years spent working to serve the interests of a diverse and continuously expanding client base. As one of the first international firms to open in Japan, Jones Day’s life sciences practice was instrumental in the development of our office in Tokyo and was a key player in the mergers of major domestic pharmaceutical companies that reshaped the Japanese market, including Sumitomo Pharmaceutical’s merger with Dainippon Pharmaceuticals.
 
Our team of Japanese bengoshi and foreign attorneys - each of whom possessing more than 20 years of experience in their area of practice - advise leading domestic and international life sciences companies on the full scope of issues affecting them, including:

• major domestic and cross-border acquisitions and joint ventures;
• co-development, licensing, distribution and other strategic arrangements;
• high-stakes litigation, arbitration and other dispute resolution involving, among others, Hatch-Waxman disputes and patent infringement;
• antitrust matters;
• data privacy, including the international transmission of patient data;
• investigations involving FCPA and Japan’s Pharmaceuticals and Medical Devices Act, among others;
• market entry and clinical trials in Japan.
 
The Tokyo team forms a key part of our deeply integrated global practice, which advises the world’s premier life sciences companies across offices throughout the Asia-Pacific, Europe and US.

Chambers Review

Provided by Chambers

Life Sciences - Japan

3
Band 3

What the Team is Known For

Jones Day houses a talented group distinguished for the scope of its expertise. The team is proficient in liaising with other offices in dealing with the protection and enforcement of IP assets, especially patents. The firm is also well placed to assist life sciences clients in relation to corporate transactions and can leverage its global network to assist clients with international matters.

Work Highlights

  • Jones Day advised Otsuka Pharmaceutical on an in-licence from Vivosens for the commercialisation of Vivoo in Japan.

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers

Benjamin Lang
3
Benjamin Lang
3
Band 3
Benjamin Lang is a practitioner in the field of life sciences in Japan, handling cross-border transactions for both Japanese and international clients.

He understands the culture of Japanese companies well and provides easy-to-understand explanations.

Benjamin Lang is great. He acts as a hub to lead the project and collaborates with other experts as appropriate.

Ranked Lawyers at
Jones Day

Provided by Chambers
Filter by
Band

Japan

Life Sciences

Benjamin Lang
3
Benjamin Lang
3
Band 3

Members

Provided by Jones Day

Hiromitsu Miyakawa

Maxwell Fox

Scott Jones

Head of Department

Shogo Aasji